Miller Anestesia

1173 / 2894

Generadores de pulso cardíaco implantables: marcapasos y desfibriladores-cardioversores 1173 33
Sección III
Control de la anestesia
© ELSEVIER. Fotocopiar sin autorización es un delito
estimulación con sobredetección ventricular inducida por la
unidad de electrocirugía, que provoca la «detección» de acti-
vidad ventricular por el marcapasos) o una descarga inade-
cuada (desfibrilador con sobredetección).
Supresión Afib (antes denominada Sobreestimulación Auricu-
lar Dinámica): aumento programable de la frecuencia de
estimulación en respuesta a la actividad auricular intrínseca.
La supresión Afib está diseñada para estimular la aurícula a
una frecuencia justo por encima de la frecuencia intrínseca
para evitar la fibrilación auricula Debería desconectarse
antes de la anestesia para evitar frecuencias de estimulación
elevadas.
Bibliografía
1. Chardack WM, Gage AA, Greatbatch W: A transis-
torized, self-contained, implantable pacemaker for
the long-term correction of complete heart block.
Surgery 48:643–654, 1960.
2. Saxon LA, Bristow MR, Boehmer J, et al: Predictors
of sudden cardiac death and appropriate shock in
the Comparison of Medical Therapy, Pacing, and
Defibrillation in Heart Failure (COMPANION)
Trial. Circulation 114:2766–2772, 2006.
3. Bardy GH, Lee KL, Mark DB, et al: Amiodarone or
an implantable cardioverter-defibrillator for conges-
tive heart failure. N Engl J Med 352:225–237, 2005.
4. Rasmussen MJ, Friedman PA, Hammill SC, Rea RF:
Unintentional deactivation of implantable cardio-
verter-defibrillators in health care settings. Mayo
Clin Proc 77:855–859, 2002.
5. Hauser RG, Kallinen L: Deaths associated with
implantable cardioverter defibrillator failure and
deactivation reported in the United States Food and
Drug Administration Manufacturer and User Faci-
lity Device Experience Database. Heart Rhythm
1:399–405, 2004.
6. Maisel WH, Moynahan M, Zuckerman BD, et al:
Pacemaker and ICD generator malfunctions: Analy-
sis of Food and DrugAdministration annual reports.
JAMA 295:1901–1906, 2006.
7. Bernstein AD, Irwin ME, Parsonnet V, et al: Report of
the NASPE Policy Conference on antibradycardia
pacemakerfollow-up:Effectiveness,needs,andresour-
ces. North American Society of Pacing and Electro-
physiology. Pacing Clin Electrophysiol 17:1714–1729,
1994.
8. Guidant: Urgent medical device safety information
and corrective action (Contak Renewal [3,4,RF]
ICD [magnet switch]). Published June 23, 2005.
Available at
9. Medtronic: Urgent medical device information:
Sprint Fidelis lead patient management recommen-
dations. Published October 15, 2007. Available at
Accessed October 19, 2007.
10. Practice advisory for the perioperative management of
patients with cardiac rhythm management devices:
Pacemakers and implantable cardioverter-defibrilla-
tors: A report by the American Society of Anesthesio-
logists Task Force on Perioperative Management of
Patients with Cardiac Rhythm Management Devices.
Anesthesiology 103:186–198, 2005.
11. Fleisher LA, Beckman JA, Brown KA, et al. ACC/
AHA 2007 guidelines on perioperative cardiovascular
evaluation and care for noncardiac surgery. A report
of the American College of Cardiology/American
Heart Association Task Force on practice guidelines
(Writing Committee to Revise the 2002 Guidelines
on Perioperative Cardiovascular Evaluation for Non-
cardiac Surgery). Published September 27, 2007.
Available at
Accessed November 16, 2007.
12. Goldschlager N, Epstein A, Friedman P, et al: Envi-
ronmental and drug effects on patients with pace-
makers and implantable cardioverter/defibrillators:
A practical guide to patient treatment. Arch Intern
Med 161:649–655, 2001.
13. Pinski SL, Trohman RG: Interference in implanted
cardiac devices, part I. Pacing Clin Electrophysiol
25:1367–1381, 2002.
14. Pinski SL, Trohman RG: Interference in implanted
cardiac devices, part II. Pacing Clin Electrophysiol
25:1496–1509, 2002.
15. Stone KR, McPherson CA: Assessment and manage-
ment of patients with pacemakers and implantable
cardioverter defibrillators. Crit Care Med 32:S155–
S165, 2004.
16. Kazatsker M, Kusniek J, Hasdai D, et al: Two pace-
makers in one patient: A stimulating case. J Cardio-
vasc Electrophysiol 13:522, 2002.
17. Marangell LB,Martinez M,Jurdi RA,Zboyan H: Neu-
rostimulation therapies in depression: A review of
new modalities. Acta Psychiatr Scand 116:174–181,
2007.
18. Zamotrinsky AV, Kondratiev B, de Jong JW: Vagal
neurostimulation in patients with coronary artery
disease. Auton Neurosci 88:109–116, 2001.
19. Lamas GA, Rebecca GS, Braunwald NS, Antman
EM: Pacemaker malfunction after nitrous oxide
anesthesia. Am J Cardiol 56:995, 1985.
20. Bernstein AD, Daubert JC, Fletcher RD, et al: The
revised NASPE/BPEG generic code for antibrady-
cardia, adaptive-rate, and multisite pacing. North
American Society of Pacing and Electrophysiology/
British Pacing and Electrophysiology Group. Pacing
Clin Electrophysiol 25:260–264, 2002.
21. Forand JM, Schweiss JF: Pacemaker syndrome
during anesthesia. Anesthesiology 60:588–590,
1984.
22. Ducey J, Fincher D, Baysinger C: Therapeutic
suppression of a permanent ventricular pacemaker
using a peripheral nerve stimulator. Anesthesiology
75:533–536, 1991.
23. Schwartzenburg CF,Wass CT, Strickland RA, Hayes
DL: Rate-adaptive cardiac pacing: Implications of
environmental noise during craniotomy. Anesthe-
siology 87:1252–1254, 1997.
24. Lau W, Corcoran SJ, Mond HG: Pacemaker tachy-
cardia in a minute ventilation rate–adaptive pace-
makerinducedbyelectrocardiographicmonitoring.
Pacing Clin Electrophysiol 29:438–440, 2006.
25. von Knobelsdorff G, Goerig M, Nagele H, Scholz J:
[Interaction of frequency-adaptive pacemakers and
anesthetic management. Discussion of current lite-
rature and two case reports]. Anaesthesist 45:
856–860, 1996.
26. Delfaut P,Saksena S: Electrophysiologic assessment
in selecting patients for multisite atrial pacing.
J Interv Card Electrophysiol 4(Suppl 1)81–85,
2000.
27. Peters RW, Gold MR: Pacing for patients with con-
gestive heart failure and dilated cardiomyopathy.
Cardiol Clin 18:55–66, 2000.
28. Abraham WT, Fisher WG, Smith AL, et al: Cardiac
resynchronization in chronic heart failure. N Engl J
Med 346:1845–1853, 2002.
29. Hare JM: Cardiac-resynchronization therapy for
heart failure. N Engl J Med 346:1902–1905, 2002.
30. Atlee J, Bernstein A: Cardiac rhythm management
devices part I. Anesthesiology 95:1265–1280, 2001.
31. Hayes DL: Evolving indications for permanent
pacing. Am J Cardiol 83:161D–165D, 1999.
32. Auricchio A, Stellbrink C, Sack S, et al: The pacing
therapies for congestive heart failure (PATH-CHF)
study: Rationale, design, and endpoints of a pros-
pective randomized multicenter study.Am J Cardiol
83:130D–135D, 1999.
33. Garcia-Moran E, Mont L, Brugada J: Inappropriate
tachycardia detection by a biventricular implanta-
ble cardioverter defibrillator. Pacing Clin Electro-
physiol 25:123–124, 2002.
34. Schreieck J, Zrenner B, Kolb C, et al: Inappropriate
shock delivery due to ventricular double detection
with a biventricular pacing implantable cardiover-
ter defibrillator.Pacing Clin Electrophysiol 24:1154–
1157, 2001.
35. Gras D, Mabo P, Tang T, et al: Multisite pacing as a
supplemental treatment of congestive heart failure:
Preliminary results of theMedtronic Inc.InSync Study.
Pacing Clin Electrophysiol 21:2249–2255, 1998.
36. Medina-Ravell VA, Lankipalli RS, Yan GX, et al:
Effect of epicardial or biventricular pacing to
prolong QT interval and increase transmural dis-
persion of repolarization: Does resynchronization
therapy pose a risk for patients predisposed to long
QT or torsades de pointes? Circulation 107:
740–746, 2003.
37. Rozner MA, Gursoy S, Monir G: Care of the patient
with a pacemaker. In Stone DJ, Bogdanoff DL,
Leisure GS, et al (eds): Perioperative Care: Anesthe-
sia, Surgery and Medicine. Philadelphia, CV Mosby,
1997, pp 53–67.
38. Purday JP, Towey RM: Apparent pacemaker failure
caused by activation of ventricular threshold test by
a magnetic instrument mat during general anaes-
thesia. Br J Anaesth 69:645–646, 1992.
39. Bourke ME:The patient with a pacemaker or related
device. Can J Anaesth 43:24–41, 1996.
40. ShapiroWA,Roizen MF,Singleton MA,et al: Intrao-
perative pacemaker complications. Anesthesiology
63:319–322, 1985.
41. Valls-Bertault V, Mansourati J, Gilard M, et al:
Adverse events with transvenous left ventricular
pacing in patients with severe heart failure: Early
experience from a single centre. Europace 3:60–63,
2001.
42. Alonso C, Leclercq C, d’Allonnes FR, et al: Six year
experience of transvenous left ventricular lead
implantation for permanent biventricular pacing in
patients with advanced heart failure: Technical
aspects. Heart 86:405–410, 2001.
43. Rozner MA, Nguyen AD, Roberson JC: Inadequate
pacemaker follow-up detected at the preanesthetic
visit. Anesthesiology 96:A1071, 2002.